Form 4: Neuronetics Director Sheryl L Conley Increases Stake in Company
SEC Form 4 Filing
Director Sheryl L Conley purchased 44,444 shares of Neuronetics, Inc. common stock at $2.25 per share in a firm commitment underwritten offering.
Summary
- On February 7, 2025, Sheryl L Conley, a director of Neuronetics, Inc., acquired 44,444 shares of common stock.
- The purchase was made at a price of $2.25 per share.
- This transaction was part of a firm commitment underwritten offering.
- Following the transaction, Conley's total holdings in Neuronetics common stock increased to 184,390 shares.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the director's purchase of shares, indicating confidence in the company. However, the context of an underwritten offering suggests the company may need capital, which could be a neutral or slightly negative factor.
Positives
- A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by a director is generally viewed as a positive sign.
Stakeholder Impact
- The director's purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of transaction: Sheryl L Conley purchased 44,444 shares of Neuronetics common stock. |
| 02/10/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.